Tumor

Pediatric researchers have developed a technique that sees tumor-seeking probes attach to cancer cells and emit fluorescence under short-wave infrared light, opening the door for much better surgery and outcomes for kids with neuroblastoma

Cancer tumors are particularly adept at evading the body’s immune response, making treatment difficult. A new study has genetically engineered a common gut bacteria, enabling it to seek out and destroy cancer tumors from the inside.

Metastatic breast cancer is stubbornly resistant to current immunotherapies. But scientists have identified a dual-therapy attack to really fire up the immune system's cells, killing existing tumors and acting like a vaccine against future ones.

Researchers in Japan have demonstrated a promising new cancer treatment. The team developed artificial DNA sequences shaped like hairpins that latch onto molecules overexpressed in cancer and trigger a strong immune response.

Immunotherapy is a promising cancer treatment, but getting it to work against solid tumors is difficult. A new study has not only identified a drug that’s effective against solid tumors, but may have uncovered a reason that immunotherapy often fails.

Preliminary results from an ongoing Phase 1/2 human trial indicate a new drug dubbed OMO-103 can safely and effectively inhibit the function of a gene known to drive the growth of many common forms of cancer.

Scientists at the University of California San Francisco have found a way to fight one of the most common cancer-causing mutations. The new drug puts up an “eat me” marker that can help the immune system or other drugs find and kill the cancer.

Earlier this year, scientists demonstrated "drug factory" beads that could be implanted alongside ovarian and colorectal tumors in mice to destroy them in less than a week. A new study focusing on another cancer type has now produced similar results.

Researchers have created a new mRNA vaccine for cancer that’s designed to carry its cargo to the lymph nodes rather than the liver. Tests in mice showed significant inhibition of the tumors, with complete remission in a decent percentage of cases.

Scientists in Spain have uncovered a mechanism behind why some cancer patients don’t respond well to treatments – and more importantly, found a “weak spot” that could be targeted by existing drugs.

A research team working to better understand the movements of cancerous cells has made an important breakthrough, describing a "sweet spot" where these cells like to congregate, which could reveal new ways to stop them in their tracks.

Researchers have found that adding a booster protein can significantly improve the outcome of cancer immunotherapy. Tests in mice showed the protein produced 10,000 times more cancer-targeting immune cells, with all mice surviving the experiment.